| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |